Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Progyny, Inc. Stock Research

PGNY

34.55USD-0.19(-0.55%)Market Closed
Watchlist

Market Summary

USD34.55-0.19
Market Closed
-0.55%

PGNY Alerts

PGNY Stock Price

PGNY RSI Chart

PGNY Valuation

Market Cap

3.3B

Price/Earnings (Trailing)

66.71

Price/Sales (Trailing)

3.43

EV/EBITDA

58.39

Price/Free Cashflow

19.88

PGNY Price/Sales (Trailing)

PGNY Profitability

EBT Margin

4.69%

Return on Equity

10.15%

Return on Assets

6.63%

Free Cashflow Yield

5.03%

PGNY Fundamentals

PGNY Revenue

Revenue (TTM)

957.5M

Revenue Y/Y

43.27%

Revenue Q/Q

8.12%

PGNY Earnings

Earnings (TTM)

49.3M

Earnings Y/Y

70.97%

Earnings Q/Q

-15.2%

Price Action

52 Week Range

28.0345.98
(Low)(High)

Last 7 days

-5.1%

Last 30 days

-7.1%

Last 90 days

-9.2%

Trailing 12 Months

-15.8%

PGNY Financial Health

Current Ratio

2.55

PGNY Investor Care

Shares Dilution (1Y)

3.48%

Diluted EPS (TTM)

150.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for PGNY

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2024-11-23
Payson Norman
sold
-11,258
56.29
-200
-
2023-09-11
Livingston Mark S.
sold (taxes)
-4,066
36.31
-112
chief financial officer
2023-09-05
Sturmer Michael E
sold (taxes)
-8,370
37.37
-224
president
2023-09-01
Livingston Mark S.
sold (taxes)
-88,794
37.34
-2,378
chief financial officer
2023-08-28
Sturmer Michael E
sold (taxes)
-298,180
37.38
-7,977
president
2023-08-28
Livingston Mark S.
sold (taxes)
-5,906
37.38
-158
chief financial officer
2023-08-07
TPG GP A, LLC
sold
-119,132,000
41.08
-2,900,000
-
2023-07-25
Livingston Mark S.
sold (taxes)
-8,902
39.22
-227
chief financial officer
2023-07-14
Anevski Peter
sold
-700,710
38.95
-17,990
chief executive officer
2023-07-14
Anevski Peter
acquired
71,060
3.95
17,990
chief executive officer

1–10 of 50

Which funds bought or sold PGNY recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-12
Farther Finance Advisors, LLC
unchanged
-
29.00
157
-%
2023-08-24
Alberta Investment Management Corp
sold off
-100
-1,283,000
-
-%
2023-08-23
WOLVERINE TRADING, LLC
new
-
284,666
284,666
-%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
10.82
130,000
495,000
-%
2023-08-21
OSAIC HOLDINGS, INC.
added
2.45
379,195
1,866,840
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
3.52
803,565
3,803,510
-%
2023-08-16
Nuveen Asset Management, LLC
added
5.21
13,001,000
58,059,000
0.02%
2023-08-15
Bullseye Asset Management LLC
unchanged
-
582,000
3,169,000
1.59%
2023-08-15
Belpointe Asset Management LLC
sold off
-100
-40,535
-
-%
2023-08-15
NATIXIS ADVISORS, L.P.
added
19.83
594,000
1,865,000
0.01%

1–10 of 47

Latest Funds Activity

Are funds buying PGNY calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PGNY
No. of Funds

Schedule 13G FIlings of Progyny

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
macquarie group ltd
5.37%
4,988,789
SC 13G/A
Feb 14, 2023
alger associates inc
2.6%
2,372,711
SC 13G/A
Feb 09, 2023
vanguard group inc
7.91%
7,345,124
SC 13G/A
Jan 06, 2023
blackrock inc.
10.1%
9,346,854
SC 13G/A
Feb 14, 2022
macquarie group ltd
8.26%
7,471,794
SC 13G/A
Feb 14, 2022
alger associates inc
5.0%
4,560,319
SC 13G
Feb 11, 2022
kleiner perkins caufield & byers xiii, llc
7.2%
6,473,515
SC 13G/A
Feb 11, 2022
tpg gp a, llc
11.6%
10,565,351
SC 13G/A
Feb 04, 2022
blackrock inc.
8.8%
7,923,625
SC 13G
May 10, 2021
alger associates inc
4.65%
4,077,636
SC 13G/A

Recent SEC filings of Progyny

View All Filings
Date Filed Form Type Document
Sep 13, 2023
4
Insider Trading
Sep 06, 2023
4
Insider Trading
Sep 06, 2023
4
Insider Trading
Sep 01, 2023
4
Insider Trading
Sep 01, 2023
4
Insider Trading
Aug 30, 2023
4
Insider Trading
Aug 30, 2023
4
Insider Trading
Aug 09, 2023
4
Insider Trading
Aug 07, 2023
144
Notice of Insider Sale Intent
Aug 04, 2023
10-Q
Quarterly Report

PGNY Fair Value

Loading...

Peers (Alternatives to Progyny)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
69.4B
61.9B
-5.48% 22.03%
12.02
1.12
3.02% -11.37%
18.2B
14.1B
-4.55% -8.18%
21.91
1.29
-5.68% -58.27%
14.0B
9.5B
-5.94% 0.52%
17.63
1.48
-10.34% -46.50%
MID-CAP
9.4B
11.7B
0.39% 9.62%
20.16
0.8
0.96% -43.93%
9.0B
13.8B
-0.58% 29.41%
13.07
0.66
5.76% -10.75%
7.8B
2.2B
1.79% 5.96%
34.39
3.56
2.13% -18.31%
7.0B
4.6B
-0.86% 34.26%
22.16
1.52
9.56% -4.24%
6.5B
2.8B
-6.98% -17.23%
23.9
2.33
13.40% -2.45%
3.3B
957.5M
-7.09% -15.76%
66.71
3.43
55.17% 8.05%
3.2B
4.4B
-1.92% -18.46%
10.02
0.73
-16.06% -30.43%
SMALL-CAP
274.6M
156.1M
-10.40% 25.13%
37.41
1.76
23.12% -14.70%
4.7M
10.8M
-41.21% -72.60%
-0.13
0.43
-71.53% 35.85%
-
6.9M
- -
-
-
-59.04% -71.13%

Progyny News

Nasdaq
Interesting PGNY Put And Call Options For February 2024.
Nasdaq,
2 days ago
StreetInsider.com
The Motley Fool
StreetInsider.com
Form N-PX Thrivent ETF Trust For: Jun 30.
StreetInsider.com,
26 days ago
Simply Wall St
StreetInsider.com
Form N-PX HSBC FUNDS For: Jun 30.
StreetInsider.com,
36 days ago

Returns for PGNY

Cumulative Returns on PGNY

9.7%


3-Year Cumulative Returns

Risks for PGNY

What is the probability of a big loss on PGNY?

85.4%


Probability that Progyny stock will be more than 20% underwater in next one year

68.5%


Probability that Progyny stock will be more than 30% underwater in next one year.

53.9%


Probability that Progyny stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does PGNY drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Progyny was unfortunately bought at previous high price.

Drawdowns

Financials for Progyny

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Last 12 Months)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue9.7%957,459873,090786,913700,145617,058550,705500,621473,369450,013385,967344,858309,679271,947263,510229,683193,748160,350130,339105,400101,61796,830
Gross Profit8.7%209,770193,016167,325147,946130,443116,177112,135107,686100,03082,36470,05961,16252,64652,14345,50539,15131,87825,46419,43418,69217,944
Operating Expenses6.7%165,014154,606143,984128,099112,78695,70279,79573,99770,57865,64061,71152,83146,07442,14535,82831,32127,70423,96122,88622,35722,268
  S&GA Expenses7.8%53,81249,92445,65740,37333,64826,18020,17917,25916,17315,75315,00613,48513,31312,82211,90110,7899,2547,8687,2856,8566,988
EBITDA-100.0%-44,31626,85621,71019,09222,23134,19735,81931,55818,49110,7065,281-7,664-5,060-6,482------
EBITDA Margin-100.0%-0.05*0.03*0.03*0.03*0.04*0.07*0.08*0.07*0.05*0.03*0.02*-0.03*-0.02*-0.03*------
Interest Expenses41.0%2,2901,624814337279491461361200-47.00121274263130-58.00-232-231-447-497-612-864
Earnings Before Taxes20.2%49,17840,91424,44119,90217,48020,49732,43534,00929,71416,7308,6793,026-9,981-7,333-8,557-6,204449-2,255-6,893-6,358-6,474
EBT Margin-100.0%-0.05*0.03*0.03*0.03*0.04*0.06*0.07*0.07*0.04*0.03*0.01*-0.04*-0.03*-0.04*------
Net Income14.5%49,28843,06530,35842,03045,61555,57465,76989,76177,78757,99646,4592,987-10,045-7,461-8,569-5,6941,380-9716612,9156,644
Net Income Margin-100.0%-0.05*0.04*0.06*0.07*0.10*0.13*0.19*0.17*0.15*0.13*0.01*-0.04*-0.03*-0.04*------
Free Cashflow-100.0%-108,91677,15434,56138,35211,69323,90822,14513,88023,88235,16620,95911,23813,253-4,490------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32018Q4
Assets4.9%68265054351046341635833731229525420217818015073.0041.00
  Current Assets6.5%56152743440235630925925423822819018516016213253.0025.00
    Cash Equivalents9.8%17115512073.0055.0039.0091.0092.0049.0030.0070.0054.0049.0092.0080.008.000.00
  Net PPE6.9%9.009.008.007.006.006.005.005.004.004.003.004.004.004.003.001.001.00
  Goodwill0%12.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.0012.00
Liabilities-5.9%21222516616415213610611310811087.0075.0058.0059.0036.0058.0030.00
  Current Liabilities-6.3%19420716015714512999.0010499.0010178.0074.0058.0059.0036.0058.0030.00
Shareholder's Equity10.6%469424377347311280252224205185167126119119114--
  Retained Earnings32.9%61.0046.0028.0025.0011.003.00-2.42-17.50-34.30-53.03-68.19-105-111-109-113-109-104
  Additional Paid-In Capital7.8%40937935032330127825524324023923623423223222919.0011.00
Shares Outstanding0.9%95.0094.0093.0092.0092.0091.0091.0090.0088.0087.0087.0086.0085.0085.0084.007.005.00
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32017Q4
Cashflow From Operations50.4%16911380.0038.0041.0014.0026.0024.0015.0025.0036.0024.0015.0017.00-1.538.003.00-4.152.00-2.43-9.47
  Share Based Compensation7.6%11510710186.0070.0053.0034.0023.0019.0016.0013.0011.009.007.005.004.003.002.003.003.002.00
Cashflow From Investing-487.9%-45.8412.00-43.87-49.00-24.758.009.0027.00-4.56-77.86-40.03-54.20-45.47-3.52-2.76-0.60-0.24-0.102.003.00-0.61
Cashflow From Financing3.0%-7.70-7.94-7.86-8.39-10.22-12.97-13.69-12.46-11.01-8.55-6.2576.0080.0078.0085.000.00-2.485.00-8.74-6.3012.00
  Buy Backs---------------0.00---1.002.00-

PGNY Income Statement

2023-06-30
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Statements of Operations    
Revenue$ 279,373$ 195,004$ 537,767$ 367,221
Cost of services218,732151,117418,486290,385
Gross profit60,64143,887119,28176,836
Operating expenses:    
Sales and marketing15,38411,49629,66621,511
General and administrative30,07323,55359,42046,545
Total operating expenses45,45735,04989,08668,056
Income from operations15,1848,83830,1958,780
Other income (expense), net:    
Other income (expense), net1,277251,775(71)
Interest income, net706401,52852
Total other income (expense), net1,983653,303(19)
Income before income taxes17,1678,90333,4988,761
(Provision) benefit for income taxes(2,176)(135)(829)4,978
Net income$ 14,991$ 8,768$ 32,669$ 13,739
Net income per share:    
Basic (in dollars per share)$ 160$ 0.10$ 350$ 0.15
Diluted (in dollars per share)$ 150$ 0.09$ 330$ 0.14
Weighted-average shares used in computing net income per share:    
Basic (in shares)94,738,65191,964,97894,290,65391,578,707
Diluted (in shares)100,615,91999,672,769100,391,57399,725,564

PGNY Balance Sheet

2023-06-30
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 170,570$ 120,078
Marketable securities111,92569,222
Accounts receivable, net of $37,892 and $28,328 of allowances at June 30, 2023 and December 31, 2022, respectively264,958240,067
Prepaid expenses and other current assets13,6774,489
Total current assets561,130433,856
Property and equipment, net9,4978,371
Operating lease right-of-use assets18,4516,903
Goodwill11,88011,880
Intangible assets, net099
Deferred tax assets77,06577,889
Other noncurrent assets3,5143,988
Total assets681,537542,986
Current liabilities:  
Accounts payable130,160109,287
Accrued expenses and other current liabilities63,74050,249
Total current liabilities193,900159,536
Operating lease noncurrent liabilities18,1386,482
Total liabilities212,038166,018
Commitments and Contingencies (Note 6)
STOCKHOLDERS' EQUITY  
Common stock, $0.0001 par value; 1,000,000,000 shares authorized at June 30, 2023 and December 31, 2022; 95,165,253 and 93,301,156 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively99
Additional paid-in capital408,814349,533
Treasury stock, at cost, $0.0001 par value; 615,980 shares at June 30, 2023 and December 31, 2022(1,009)(1,009)
Accumulated earnings60,60327,934
Accumulated other comprehensive income1,082501
Total stockholders’ equity469,499376,968
Total liabilities and stockholders’ equity$ 681,537$ 542,986
Peter Anevski
310
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.